Clinical Trials – Bumetanide and Memantine & Making Sense of it all in a Single Book
This week I received a message: - “Your Bumetanide treatment is on trial among 25 teenagers here and parents are loving it” My reply, brief as usual (unlike my blog posts) “Great!” I did not mention that in the first phase of the trial 50% of the teenagers are going to be on the placebo. It is Dr Ben-Ari’s treatment. A clinician told me that all the parents of children, to whom she has prescribed bumetanide, think their children are responders and is wondering how to deal with the parental placebo effect. I had another clinician telling me, “I guess from your experience with the blog, most people are not responders to Bumetanide”. Then came an analysis of the recent tiny study in China that showed on average there was a measurable improvement on the CARS scale (Childhood Autism Rating Scale), but the question arose was “is this response large enough for parents to notice?” Memantine (Namenda) A few years ago, Memantine was also trialled at the University Hospital where we...